Hua Liu
Direktor/Vorstandsmitglied bei Beijing Xiangxin Biotechnology Co., Ltd.
Profil
Hua Liu currently works at Beijing Xiangxin Biotechnology Co., Ltd., as Director from 2019.
Dr. Liu also formerly worked at Tai United Holdings Ltd., as Executive Director from 2016 to 2017, GTJA Innovation Investment Co. Ltd., as Executive Director, and Donghai Securities Co., Ltd.
(Broker), as General Manager from 2014 to 2015.
Dr. Liu received his graduate degree from Imperial College London, doctorate degree from the University of Cambridge, and undergraduate degree from Tsinghua University.
Aktive Positionen von Hua Liu
| Unternehmen | Position | Beginn |
|---|---|---|
Beijing Xiangxin Biotechnology Co., Ltd.
 Beijing Xiangxin Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Xiangxin Biotechnology Co., Ltd. was founded in 2018 and is based in the economic-technological development area. The Chinese company has established two R & D centers covering a total area of 5,000 square meters. The company provides comprehensive solutions for cancer precision medicine using genomics technologies, with a focus on next-generation sequencing (NGS) in solid tumors and hematological malignancies. Acornmed has launched over 30 clinical testing products covering early detection and screening of multiple cancers, hereditary cancer identification, companion diagnostics for targeted therapy and immunotherapy, prognostic stratification, longitudinal monitoring of tumors, etc. The company has served more than 500 hospitals and have been endorsed by many clinical oncologists and laboratory professionals. | Direktor/Vorstandsmitglied | 07.03.2019 |
Ehemalige bekannte Positionen von Hua Liu
| Unternehmen | Position | Ende |
|---|---|---|
| TAI UNITED HOLDINGS LIMITED | Vorstandsvorsitzender | 08.06.2016 |
| Donghai Securities Co., Ltd. (Broker) | Corporate Officer/Principal | 01.11.2015 |
GTJA Innovation Investment Co. Ltd.
 GTJA Innovation Investment Co. Ltd. Investment ManagersFinance GTJA Innovation Investment Co. Ltd. is a private equity and venture capital firm founded in 2009, headquartered in Shanghai. | Direktor/Vorstandsmitglied | - |
Ausbildung von Hua Liu
| Tsinghua University | Undergraduate Degree |
| Imperial College London | Graduate Degree |
| University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TAI UNITED HOLDINGS LIMITED | Finance |
| Private Unternehmen | 3 |
|---|---|
GTJA Innovation Investment Co. Ltd.
GTJA Innovation Investment Co. Ltd. Investment ManagersFinance GTJA Innovation Investment Co. Ltd. is a private equity and venture capital firm founded in 2009, headquartered in Shanghai. | Finance |
| Donghai Securities Co., Ltd. (Broker) | Finance |
Beijing Xiangxin Biotechnology Co., Ltd.
Beijing Xiangxin Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Xiangxin Biotechnology Co., Ltd. was founded in 2018 and is based in the economic-technological development area. The Chinese company has established two R & D centers covering a total area of 5,000 square meters. The company provides comprehensive solutions for cancer precision medicine using genomics technologies, with a focus on next-generation sequencing (NGS) in solid tumors and hematological malignancies. Acornmed has launched over 30 clinical testing products covering early detection and screening of multiple cancers, hereditary cancer identification, companion diagnostics for targeted therapy and immunotherapy, prognostic stratification, longitudinal monitoring of tumors, etc. The company has served more than 500 hospitals and have been endorsed by many clinical oncologists and laboratory professionals. | Health Technology |
